The National Institutes of Health has partnered with two companies to evaluate agency facilities that produce sterile or infused medicines for clinical research use.
NIH said Tuesday preliminary findings of the assessment identified quality and safety compliance problems at a cell-therapy production laboratory and a radiopharmaceutical compound production facility.
The agency suspended operations at the facilities and halted enrollment of patients for clinical trials of the affected experimental drugs.
NIH formed a working group in December to develop management strategies for the agency’s Clinical Center Pharmaceutical Development Section and its affiliated labs and production hubs after the Food and Drug Administration found serious quality-control problems within PDS.
The Clinical Center Working Group was scheduled Thursday to submit its recommendations to NIH.
Related Articles
President Donald Trump has signed an executive order approving a proposed deal that would keep video-sharing platform TikTok operational in the U.S. while protecting national security. Engage with U.S. military leaders and top industry experts at the Potomac Officers Club’s 2025 GovCon International and Global Defense Summit as they tackle global defense challenges, from supply chain risks to sanctions and international regulations. Save your spot now for this Oct. 16 event to gain critical insights and connect with key decision-makers! ‘Qualified Divestiture’ of TikTok’s US Operations In a fact sheet published Thursday, the White House said TikTok’s U.S. operations would
The Federal Risk and Authorization Management Program has announced the second phase of FedRAMP 20x, a cloud-native authorization framework that aims to advance the use of automation to accelerate secure cloud adoption across federal agencies. The program said it is targeting about 10 Moderate pilot authorizations as part of the FedRAMP 20x pilot’s Phase 2, which is not open to the public. According to FedRAMP, the Phase 2 pilot will continue to be iterative and explore an automation-based approach to assessment and validation of security decisions by cloud service providers seeking FedRAMP authorization. The submission window for this phase is
The National Institute of Standards and Technology has issued a broad agency announcement through its CHIPS Research and Development Office to solicit proposals for a funding opportunity aimed at advancing U.S. leadership in microelectronics technology. The funding opportunity calls for research, prototyping and commercialization efforts that align with critical technology needs. “We look forward to seeing ideas that together will advance microelectronics research and drive further innovation in emerging technologies such as quantum, artificial intelligence and biomanufacturing,” said Craig Burkhardt, acting under secretary of commerce for standards and technology and acting NIST director. NIST Funding Opportunity Scope, Goals and Technical